No actionable signal for NDAQ. The delistings have zero material effect on Nasdaq's revenue or financials; each suspended security was already non-trading. Monitor for any future large-scale exchange policy changes, but ignore this batch announcement for NDAQ positioning.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 10 $88.08entry
- T+1 · 4mo ago +1.28%α +2.05% · $89.21
- T+5 · 4mo ago +7.00%α +7.57% · $94.25
- T+20 · 3mo ago +7.39%α +4.97% · $94.59
- T+60 · 6w ago +4.67%α +2.03% · $92.19
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Nasdaq announced a batch delisting of 17 companies' securities, all of which were already suspended from trading. The list spans micro-cap operating companies, SPACs, and biotechs including CERo Therapeutics, Bowen Acquisition Corp, Graphjet Technology, Blue Hat Interactive, X3 Holdings, Captivision, Actelis Networks, American Rebel Holdings, Reviva Pharmaceuticals, Alchemy Investments, Bitcoin Depot, Inotiv, GoHealth, Functional Brands, Sleep Number, Smart Digital Group, and REE Automotive. This is a routine administrative action for Nasdaq, the suspensions predate today's announcement and no new exchange-level event is occurring.
Key Facts
- 17 companies' securities are being delisted, all previously suspended (latest suspension June 26, 2026, earliest October 31, 2025)
- No financial details, no pricing, and no Nasdaq market impact disclosed
- Securities listed for delisting include common stock, warrants, units, rights, and Class A shares across different entity types
Financial Impact
No financial impact on Nasdaq, Inc. disclosed; this is a routine delisting clean-up action
Risk Factors
- Reputational monitoring if large number of non-compliance lists persist, but immaterial to near-term financials
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3325637 |
Track record
53 reports on NDAQ
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.20% at T+20 after the Oct 15, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $108.54 Now $108.52 +0.01% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $108.47 Now $108.52 +0.05% settles Feb 11
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $108.47 Now $108.52 +0.05% settles Feb 11
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $109.68 Now $108.52 −1.06% settles Feb 9
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $108.50 Now $108.52 +0.02% settles Feb 5
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $107.12 Now $108.52 +1.31% settles Feb 4
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $106.83 Now $108.52 +1.58% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $106.83 Now $108.52 +1.58% settles Feb 3
- Nov 4, 202612d ago 3 Neutral 1/10 Entry $106.83 Now $108.52 +1.58% settles Feb 3
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $109.70 Now $108.52 −1.08% settles Feb 2
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers